Could Recursion Pharmaceuticals Be the Next Big Artificial Intelligence (AI) Stock?

Artificial intelligence (AI) has the potential to transform all sectors and industries throughout the economy. Investing in companies that are involved in this transformation can potentially result in massive returns in the long run.One healthcare company that is looking to leverage AI is Recursion Pharmaceuticals (NASDAQ: RXRX). It has been partnering with many big drug companies as it looks to revolutionize the process of drug discovery, which can help speed up innovation and reduce costs for pharmaceutical businesses.With some intriguing opportunities ahead, could this be the next big AI stock to own, and is it worth investing in Recursion Pharmaceuticals today?Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool